Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Recommendations	Amarin remains undervalued under almost any scenario, says Cowen » 07:51 01/22/21 01/22 07:51 01/22/21 07:51 AMRN Amarin $6.31 / +0.11 (+1.78%) Cowen analyst Ken… Cowen analyst Ken Cacciatore believes Amarin shares remain undervalued remain undervalued under almost any scenario and said its valuation appears too discounted. He believes the company's best path forward it to cease US promotional spending to maximize profitability and then sell the company for European value, Cacciatore maintained his Outperform rating and $10 price target on Amarin shares. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMRN Amarin $6.31 / +0.11 (+1.78%) 01/21/21 Amarin announces CSC included icosapent ethyl in CD prevention guidelines 01/07/21 Amarin provides outlook on 2021 cash & expenses 12/14/20 Amarin says Vascepa reduced Covid inflammation by 25% in early study 12/14/20 Amarin announces presentation of Vascepa findings at conference AMRN Amarin $6.31 / +0.11 (+1.78%) 01/08/21 Piper Sandler Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target 12/28/20 Cantor Fitzgerald Vascepa showing positive year-over-year trends, says Cantor Fitzgerald 12/23/20 Goldman Sachs Amarin price target lowered to $6 from $8 at Goldman Sachs 12/14/20 Piper Sandler Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper AMRN Amarin $6.31 / +0.11 (+1.78%) 01/07/21 Amarin sees FY20 revenue up 42% to $610M, consensus $619.19M 11/05/20 Amarin reports Q3 non-GAAP EPS (1c), consensus 1c 08/04/20 Amarin reports Q2 adjusted EPS 4c, consensus (7c) AMRN Amarin $6.31 / +0.11 (+1.78%) 11/04/20 Amarin loses bid for rehearing of Vascepa case, Bloomberg says AMRN Amarin $6.31 / +0.11 (+1.78%) 01/21/21 Fly Intel: After-Hours Movers 12/14/20 Amarin rises following 'encouraging' results in COVID patients 10/26/20 Fly Intel: Pre-market Movers 10/15/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference AMRN Amarin $6.31 / +0.11 (+1.78%) 01/08/21 Amarin call volume above normal and directionally bullish 01/04/21 Amarin call volume above normal and directionally bullish 12/17/20 Amarin call volume above normal and directionally bullish 12/14/20 Unusually active option classes on open December 14th

Yesterday
On The Fly	Fly Intel: After-Hours Movers » 18:35 01/21/21 01/21 18:35 01/21/21 18:35 SIVB SVB Financial $455.02 / -7.49 (-1.62%) , WAL Western Alliance $69.40 / -1.92 (-2.69%) , INDB Independent Bank $78.68 / -1.39 (-1.74%) , OZK Bank OZK $34.03 / -0.59 (-1.70%) , FLDM Fluidigm $6.17 / +0.31 (+5.29%) , MNOV MediciNova $5.78 / +0.09 (+1.58%) , SWIR Sierra Wireless $18.41 / +0.02 (+0.11%) , ALDX Aldeyra $11.77 / -0.48 (-3.92%) , AMRN Amarin $6.31 / +0.11 (+1.78%) , IBM IBM $131.80 / +1.72 (+1.32%) , STX Seagate $63.00 / +1.57 (+2.56%) , PPG PPG $143.94 / -0.635 (-0.44%) , ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) , CSX CSX $91.61 / -1.6101 (-1.73%) , PGEN Precigen $9.18 / -0.22 (-2.34%) , ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) , F Ford $11.53 / +0.665 (+6.12%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SWIR STX SIVB PPG PGEN OZK MNOV ISRG IBM FLDM F CSX AMRN ALDX ACB SWIR Sierra Wireless $18.41 / +0.02 (+0.11%) 01/21/21 Sierra Wireless CEO Thexton to retire 11/18/20 Sierra Wireless completes divestiture of automotive embedded module product line 07/23/20 Sierra Wireless to divest automotive embedded product line for $165M STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate says 2020 'a very challenging year' 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products SIVB SVB Financial $455.02 / -7.49 (-1.62%) 01/05/21 HoldCo expresses concerns regarding Boston Private Financial, SVB Financial deal 01/04/21 SVB Financial to acquire Boston Private Financial in $900M cash and stock deal 12/08/20 Clearbanc, Silicon Valley Bank partner on new capital program 11/30/20 SVB Financial to acquire WestRiver Group's debt investment business PPG PPG $143.94 / -0.635 (-0.44%) 01/21/21 PPG says demand continues to improve in many of its end-use markets 01/11/21 PPG appoints Bhaskar Ramachandran as CIO 01/11/21 PPG reaches definitive agreement to acquire Worwag 01/08/21 PPG to acquire VersaFlex Family of Companies PGEN Precigen $9.18 / -0.22 (-2.34%) 01/05/21 Precigen announces FDA clearance of IND application for PRGN-2012 12/07/20 Precigen: PRGN-3006 safe, well-tolerated to date 11/16/20 Precigen announces dosing of first patients in ongoing PRGN-3005, -3006 trials 10/15/20 Precigen's UltraPorator system receives FDA clearance OZK Bank OZK $34.03 / -0.59 (-1.70%) 01/04/21 Bank OZK increases quarterly cash dividend to 27.75c per share 10/08/20 Bank OZK reports resignation of Chief Credit Officer of the bank 10/01/20 Bank OZK raises quarterly dividend to 27.5c per share MNOV MediciNova $5.78 / +0.09 (+1.58%) 01/21/21 MediciNova rises 14% after disclosing activist stake by 3D Investment Partners 12/29/20 MediciNova receives notice of allowance for patent covering MN-166 12/15/20 MediciNova to be added to Nasdaq Biotechnology Index at open on 12/21 11/25/20 MediciNova's MN-166 shows retinal thinning attenuation in Phase 2b trial ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Intuitive Surgical says overall procedure growth was 6% in Q4 10/27/20 Intuitive Surgical launches $100M venture capital fund 10/15/20 Intuitive Surgical slides 2.8% to $720 per share after Q3 results 10/15/20 Intuitive Surgical's first 9 months of 2020 saw 'significant impact' from COVID IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 IBM down 6.5% at $123.24 after Q4 earnings, conference call outlook 01/21/21 IBM sees FY21 'revenue growth based on current spot rates' 01/21/21 IBM NewCo CEO Martin Schroeter says company has 'tremendous potential' 01/21/21 IBM CFO says optimizing NewCo to have a 'leaner' operating model FLDM Fluidigm $6.17 / +0.31 (+5.29%) 01/21/21 Fluidigm gets CE-IVD mark for its saliva-based Advanta assay for Covid 01/05/21 Fluidigm announces publication on potential for Imaging Mass Cytometry 11/24/20 Fluidigm says India CDSCO grants commercial license for Advanta Dx Assay 11/19/20 Fluidigm announces results of study using Imaging Mass Cytometry F Ford $11.53 / +0.665 (+6.12%) 01/21/21 Ford sees 2020 underfunded status for pension of about $6.7B 01/21/21 Ford to replace Takata airbag inflators in certain models at cost of $610M 01/19/21 EU passenger car registrations down 3.3% in December 01/11/21 Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B CSX CSX $91.61 / -1.6101 (-1.73%) 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 AMRN Amarin $6.31 / +0.11 (+1.78%) 01/21/21 Amarin announces CSC included icosapent ethyl in CD prevention guidelines 01/07/21 Amarin provides outlook on 2021 cash & expenses 12/14/20 Amarin says Vascepa reduced Covid inflammation by 25% in early study 12/14/20 Amarin announces presentation of Vascepa findings at conference ALDX Aldeyra $11.77 / -0.48 (-3.92%) 01/21/21 Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors 01/07/21 Aldeyra announces top-line results from run-in cohort in Tranquility study 12/22/20 Aldeyra confirms SARS-CoV-2 antiviral activity of ADX-1612 12/17/20 Aldeyra initiates Phase 2 trials of ADX-629 ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/14/21 Aurora Cannabis announces Canadian retail sales deal with Great North 01/06/21 Aurora Cannabis rises 13.7% 01/06/21 Aurora Cannabis rises 13.8% 12/16/20 Aurora Cannabis provides business update, closing Aurora Sun facility SIVB WAL INDB OZK FLDM MNOV SWIR ALDX AMRN IBM STX PPG ISRG CSX PGEN ACB F SIVB SVB Financial $455.02 / -7.49 (-1.62%) 01/08/21 Oppenheimer Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move' 01/05/21 DA Davidson SVB Financial price target raised to $400 from $365 at DA Davidson 01/05/21 Raymond James SVB Financial price target raised to $440 from $325 at Raymond James 01/05/21 RBC Capital SVB Financial price target raised to $437 from $320 at RBC Capital WAL Western Alliance $69.40 / -1.92 (-2.69%) 01/08/21 UBS Western Alliance upgraded to Buy from Neutral at UBS 01/04/21 Stephens Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens 12/15/20 Truist Truist raises price targets on select regional banks 11/04/20 Stephens Western Alliance resumed with an Overweight at Stephens INDB Independent Bank $78.68 / -1.39 (-1.74%) 12/17/20 Seaport Global Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys 12/17/20 Seaport Global Independent Bank initiated with a Neutral at Seaport Global 10/26/20 Compass Point Independent Bank upgraded to Buy from Neutral at Compass Point 06/24/20 Piper Sandler Independent Bank downgraded to Neutral from Overweight at Piper Sandler OZK Bank OZK $34.03 / -0.59 (-1.70%) 06/17/20 Raymond James Bank OZK upgraded to Outperform from Market Perform at Raymond James 06/17/20 Citi Bank OZK downgraded to Neutral from Buy at Citi 06/17/20 Raymond James Bank OZK upgraded to Outperform from Market Perform at Raymond James 04/28/20 Truist Bank OZK price target raised to $22 from $19 at SunTrust FLDM Fluidigm $6.17 / +0.31 (+5.29%) 12/17/20 BTIG Illumina upgraded to Buy from Neutral at BTIG 11/09/20 Piper Sandler Buy companies with COVID-19 tests on today's selloff, says Piper Sandler 10/19/20 Piper Sandler Fluidigm test pact in Texas 'another validation,' says Piper Sandler 09/29/20 Piper Sandler Piper Sandler would be buyers of Fluidigm given recent pullback MNOV MediciNova $5.78 / +0.09 (+1.58%) SWIR Sierra Wireless $18.41 / +0.02 (+0.11%) 01/14/21 Fly Intel: Top five analyst initiations 01/14/21 B. Riley Securities Sierra Wireless initiated with a Buy at B. Riley Securities 11/25/20 Colliers Sierra Wireless initiated with a Buy at Colliers 02/14/20 Roth Capital Roth Capital sees upside in Sierra Wireless after 2020 transition year ALDX Aldeyra $11.77 / -0.48 (-3.92%) 01/08/21 Jefferies Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies 01/08/21 Citi Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi 01/07/21 Alliance Global Partners Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP 12/16/20 Berenberg Berenberg starts Aldeyra with Buy, sees near-term catalysts AMRN Amarin $6.31 / +0.11 (+1.78%) 01/08/21 Piper Sandler Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target 12/28/20 Cantor Fitzgerald Vascepa showing positive year-over-year trends, says Cantor Fitzgerald 12/23/20 Goldman Sachs Amarin price target lowered to $6 from $8 at Goldman Sachs 12/14/20 Piper Sandler Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper IBM IBM $131.80 / +1.72 (+1.32%) 10/20/20 Morgan Stanley Morgan Stanley continues to view IBM as 'a 2022 stock' 10/20/20 Citi IBM is 'getting even more complex,' says Citi 10/20/20 BMO Capital IBM price target lowered to $138 from $140 at BMO Capital 10/09/20 Morgan Stanley IBM price target raised to $140 from $128 at Morgan Stanley STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Barclays Seagate price target raised to $60 from $41 at Barclays 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland 01/19/21 Loop Capital Seagate price target raised to $70 from $60 at Loop Capital PPG PPG $143.94 / -0.635 (-0.44%) 01/20/21 Citi Citi adds PPG to US Focus List, removes FMC 01/14/21 Berenberg PPG upgraded to Buy with $165 price target at Berenberg 01/14/21 Berenberg PPG upgraded to Buy from Hold at Berenberg 12/01/20 Deutsche Bank PPG price target raised to $165 from $155 at Deutsche Bank ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 12/15/20 Morgan Stanley Intuitive Surgical downgraded to Equal Weight on valuation at Morgan Stanley 12/15/20 Morgan Stanley Intuitive Surgical downgraded to Equal Weight from Overweight at Morgan Stanley 11/24/20 Raymond James Intuitive Surgical not surprised by J&J robot features, says Raymond James 10/16/20 JPMorgan Intuitive Surgical price target raised to $785 from $765 at JPMorgan CSX CSX $91.61 / -1.6101 (-1.73%) 01/20/21 Susquehanna Railroad recovery expected to continue in 2021, says Susquehanna 01/11/21 Citi CSX price target raised to $105 from $87 at Citi 12/10/20 Morgan Stanley Morgan Stanley downgrades CSX to Underweight with bar raised too high 12/10/20 Morgan Stanley CSX downgraded to Underweight from Equal Weight at Morgan Stanley PGEN Precigen $9.18 / -0.22 (-2.34%) 12/16/20 H.C. Wainwright Precigen price target raised to $10 from $8 at H.C. Wainwright 05/08/20 Fly Intel: Top analyst initiations 05/08/20 H.C. Wainwright Precigen initiated with a Buy at H.C. Wainwright ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/06/21 BMO Capital Federal cannabis reform in U.S. likely to take time, says BMO Capital 12/17/20 BMO Capital Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital 12/04/20 Alliance Global Partners Alliance Global sees low odds of MORE Act passing this congressional session 12/02/20 Alliance Global Partners Alliance Global Partners sees UN cannabis reclassification helping legalization F Ford $11.53 / +0.665 (+6.12%) 01/20/21 Deutsche Bank Ford price target raised to $11 from $9 at Deutsche Bank 01/20/21 Deutsche Bank Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 12/23/20 Morgan Stanley Apple's potential EV entry represents 'new Tesla bear case,' says Morgan Stanley WAL SWIR STX SIVB PPG PGEN OZK ISRG INDB IBM FLDM F CSX AMRN ALDX ACB WAL Western Alliance $69.40 / -1.92 (-2.69%) 01/21/21 Western Alliance reports Q4 EPS $1.93 , consensus $1.32 10/22/20 Western Alliance reports Q3 EPS $1.36, consensus $1.04 SWIR Sierra Wireless $18.41 / +0.02 (+0.11%) 01/21/21 Sierra Wireless sees Q4 revenue above street consensus of $116.5M 11/12/20 Sierra Wireless cannot estimate COVID-19 impact on Q4 and beyond 11/12/20 Sierra Wireless reports Q3 EPS (19c), consensus (15c) 08/06/20 Sierra Wireless reports Q2 non-GAAP EPS (30c), consensus (35c) STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26 01/21/21 Seagate reports Q2 adjusted EPS $1.29, consensus $1.13 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c SIVB SVB Financial $455.02 / -7.49 (-1.62%) 01/21/21 SVB Financial reports Q4 EPS $7.40, consensus $3.83 10/23/20 SVB Financial reports Q3 EPS $8.47, consensus $5.14 07/23/20 SVB Financial reports Q2 EPS $4.42, consensus $3.11 PPG PPG $143.94 / -0.635 (-0.44%) 01/21/21 PPG reports Q4 EPS $1.59, consensus $1.58 10/19/20 PPG sees Q4 adjusted EPS $1.50-$1.57, consensus $1.44 10/19/20 PPG reports Q3 adjusted EPS $1.93, consensus $1.92 PGEN Precigen $9.18 / -0.22 (-2.34%) 11/09/20 Precigen reports Q3 EPS (18c), consensus (14c) 08/10/20 Precigen reports Q2 EPS (26c), consensus (13c) OZK Bank OZK $34.03 / -0.59 (-1.70%) 01/21/21 Bank OZK reports Q4 EPS 93c, consensus 78c 10/22/20 Bank OZK reports Q3 EPS 84c, consensus 58c 07/23/20 Bank OZK reports Q2 EPS 39c, consensus 33c ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Intuitive Surgical reports Q4 EPS $3.58, consensus $3.12 01/13/21 Intuitive Surgical sees 2020 revenue $4.36B, consensus $4.27B 01/13/21 Intuitive Surgical sees Q4 revenue $1.33B, consensus $1.23B INDB Independent Bank $78.68 / -1.39 (-1.74%) 01/21/21 Independent Bank reports Q4 EPS $1.05, consensus $1.03 10/22/20 Independent Bank reports Q3 adjusted EPS $1.07, consensus 81c 07/23/20 Independent Bank Corp. reports Q2 EPS 76c, consensus 62c IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 IBM reports Q4 Cloud & Cognitive Software revenue $6.8B, down 4.5% 01/21/21 IBM reports Q4 adjusted EPS $2.07, consensus $1.79 01/21/21 Notable companies reporting after market close 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% FLDM Fluidigm $6.17 / +0.31 (+5.29%) 11/05/20 Fluidigm reports Q3 EPS 3c, consensus (20c) 08/06/20 Fluidigm reports Q2 EPS (18c), consensus (23c) F Ford $11.53 / +0.665 (+6.12%) 10/28/20 Ford sees temporarily lower F-150 wholesale shipments in Q4 10/28/20 Ford reports Q3 adjusted EBIT $3.6B 10/28/20 Ford reports Q3 adjusted EPS 65c, consensus 16c 10/28/20 Notable companies reporting after market close CSX CSX $91.61 / -1.6101 (-1.73%) 01/21/21 CSX reports Q4 EPS 99c, consensus $1.00 10/21/20 CSX reports Q3 EPS 96c, consensus 92c 10/21/20 Notable companies reporting after market close AMRN Amarin $6.31 / +0.11 (+1.78%) 01/07/21 Amarin sees FY20 revenue up 42% to $610M, consensus $619.19M 11/05/20 Amarin reports Q3 non-GAAP EPS (1c), consensus 1c 08/04/20 Amarin reports Q2 adjusted EPS 4c, consensus (7c) ALDX Aldeyra $11.77 / -0.48 (-3.92%) 11/05/20 Aldeyra reports Q3 EPS (23c), consensus (27c) 08/06/20 Aldeyra reports Q2 EPS (25c), consensus (34c) ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 09/22/20 Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter 22 Jan 22 Jan 14 Jan 11 Nov IBM FLDM F AMRN ACB IBM IBM $131.80 / +1.72 (+1.32%) 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/06/21 IBM restructuring sales organization, WSJ reports 11/25/20 IBM to eliminate 10,000 positions in Europe ahead of unit sale, Bloomberg says 10/11/20 IBM split might not mean speedy recovery, WSJ says FLDM Fluidigm $6.17 / +0.31 (+5.29%) 09/18/20 Citron reiterates long position in Fluidigm with $20 price target 09/09/20 Report says U.S. may need 193M coronavirus tests per month, STAT reports 08/27/20 Abbott test approval good for Fluidigm, Citron Research says 08/26/20 Citron sees Fluidigm shares going to '$35 and higher' after EUA for COVID test F Ford $11.53 / +0.665 (+6.12%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/08/21 Ford to idle Kentucky plant, blames microchip shortage, Detroit News reports 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says AMRN Amarin $6.31 / +0.11 (+1.78%) 11/04/20 Amarin loses bid for rehearing of Vascepa case, Bloomberg says ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports 12/17/20 NJ lawmakers pass legal weed bill, now goes to Gov. Murphy, NJ.com reports STX SIVB PPG MNOV ISRG IBM FLDM F CSX AMRN ACB STX Seagate $63.00 / +1.57 (+2.56%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers SIVB SVB Financial $455.02 / -7.49 (-1.62%) 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday PPG PPG $143.94 / -0.635 (-0.44%) 10/19/20 Fly Intel: After-Hours Movers 10/09/20 GE reinstatement at Goldman among today's top calls on Wall Street MNOV MediciNova $5.78 / +0.09 (+1.58%) 09/23/20 Fly Intel: Pre-market Movers 07/27/20 Fly Intel: Pre-market Movers ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 07/21/20 Fly Intel: After-Hours Movers IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 Fly Intel: What to watch in IBM's earnings report 10/20/20 Fly Intel: Wall Street's top stories for Tuesday FLDM Fluidigm $6.17 / +0.31 (+5.29%) 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 10/24/20 Week in review: How Trump's policies moved stocks 10/19/20 Fly Intel: Pre-market Movers 09/29/20 Fly Intel: Pre-market Movers F Ford $11.53 / +0.665 (+6.12%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/22/20 Apple rises as Wall Street digests report of self-driving car plans 12/07/20 Fly Intel: Wall Street's top stories for Monday CSX CSX $91.61 / -1.6101 (-1.73%) 10/21/20 Fly Intel: After-Hours Movers AMRN Amarin $6.31 / +0.11 (+1.78%) 12/14/20 Amarin rises following 'encouraging' results in COVID patients 10/26/20 Fly Intel: Pre-market Movers 10/15/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: Wall Street's top stories for Wednesday ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/21/21 Rising High: An exclusive talk with emulsion provider SoRSE Technology 01/14/21 Rising High: An exclusive talk with cannabinoid market research firm BDSA 01/07/21 Rising High: WeedMD consolidates medical distribution activities 12/31/20 Rising High: Canopy Rivers sells Canapar stake, Stem closes Driven deal 03/01/21 41st Annual Healthcare Virtual Conference 01/21/21 Intuitive Surgical - ISRG 01/21/21 CSX - CSX 01/21/21 Seagate - STX 01/21/21 IBM - IBM 01/21/21 SVB Financial - SIVB 08:00 Today PPG - PPG 10:00 Today Independent Bank - INDB 11:00 Today Bank OZK - OZK 12:00 Today Western Alliance - WAL 02/04/21 Ford - F 02/10/21 Fluidigm - FLDM STX PPG PGEN MNOV ISRG IBM FLDM F CSX AMRN ACB STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish PPG PPG $143.94 / -0.635 (-0.44%) 10/19/20 PPG Industries options imply 4.4% move in share price post-earnings PGEN Precigen $9.18 / -0.22 (-2.34%) 12/11/20 Largest borrow rate increases among liquid names MNOV MediciNova $5.78 / +0.09 (+1.58%) 07/31/20 Largest borrow rate increases among liquid names ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 11/12/20 Early notable gainers among liquid option names on November 12th 10/15/20 Intuitive Surgical options imply 5.8% move in share price post-earnings IBM IBM $131.80 / +1.72 (+1.32%) 01/21/21 IBM options imply 6.3% move in share price post-earnings 01/05/21 Unusually active option classes on open January 5th 10/30/20 IBM call volume above normal and directionally bullish 10/19/20 IBM options imply 6.1% move in share price post-earnings FLDM Fluidigm $6.17 / +0.31 (+5.29%) 10/22/20 Largest borrow rate increases among liquid names 09/18/20 Fluidigm call volume above normal and directionally bullish 08/26/20 Fluidigm call volume above normal and directionally bullish 08/25/20 Fluidigm call volume above normal and directionally bullish F Ford $11.53 / +0.665 (+6.12%) 01/21/21 Ford call volume off to the races as shares and implied volatility surge 01/21/21 Notable open interest changes for January 21st 01/20/21 Ford call volume above normal and directionally bullish 01/20/21 Early notable gainers among liquid option names on January 20th CSX CSX $91.61 / -1.6101 (-1.73%) 01/21/21 CSX options imply 4.6% move in share price post-earnings 10/22/20 Early notable gainers among liquid option names on October 22nd 09/15/20 CSX call volume above normal and directionally bullish 09/04/20 CSX put volume heavy and directionally bearish AMRN Amarin $6.31 / +0.11 (+1.78%) 01/08/21 Amarin call volume above normal and directionally bullish 01/04/21 Amarin call volume above normal and directionally bullish 12/17/20 Amarin call volume above normal and directionally bullish 12/14/20 Unusually active option classes on open December 14th ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/13/21 Aurora Cannabis call volume above normal and directionally bullish 01/11/21 Aurora Cannabis call volume above normal and directionally bullish 11/30/20 Aurora Cannabis call buyer realizes 57% same-day gains 11/27/20 Largest borrow rate increases among liquid names
Hot Stocks	Amarin announces CSC included icosapent ethyl in CD prevention guidelines » 18:27 01/21/21 01/21 18:27 01/21/21 18:27 AMRN Amarin $6.31 / +0.11 (+1.78%) The company states:… The company states: "Amarin announced that the Chinese Society of Cardiology, or CSC, has included icosapent ethyl in its updated Guidelines for Primary Prevention of Cardiovascular Diseases for 2021 as published in the Chinese Journal of Cardiovascular Diseases. The guideline authors include "icosapent ethyl grams twice a day as a treatment consideration to further lower atherosclerotic cardiovascular disease (ASCVD) in the appropriate patient population. In November 2020, Amarin shared positive, statistically significant top-line results from a Phase 3 clinical trial of VASCEPA conducted in China by Amarin's partner, Edding. The study, which investigated VASCEPA as a treatment for patients with very high triglycerides (greater than or equal to500 mg/dL), met its primary efficacy endpoint and demonstrated a safety profile similar to placebo. This pivotal study mirrored Amarin's MARINE study in patients from the United States and other countries and showed consistency across the Chinese and non-Chinese study populations. These findings will provide support as Edding progresses towards and through the next steps of regulatory submission and review of VASCEPA for potential approval in Mainland China. The CSC recommendation is classified as a Category IIa recommendation denoting that icosapent ethyl is useful and effective and should be considered for treatment of at-risk patients. The classification is an Evidence Level B recommendation which reflects that the evidence comes from a single randomized trial or multiple large non-randomized studies. CSC cited that its recommendations are supported by the results of the REDUCE-IT cardiovascular outcomes study. The CSC does not provide endorsements of any brand name commercial product. Accordingly, CSC Guidelines for Primary Prevention of Cardiovascular Diseases reference icosapent ethyl. The CSC guideline does not reference VASCEPA, the brand name of icosapent ethyl in the United States, and such guideline should not be construed as an endorsement or approval by the CSC of VASCEPA." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMRN Amarin $6.31 / +0.11 (+1.78%) 01/07/21 Amarin provides outlook on 2021 cash & expenses 12/14/20 Amarin says Vascepa reduced Covid inflammation by 25% in early study 12/14/20 Amarin announces presentation of Vascepa findings at conference 11/30/20 Amarin files patent infringement lawsuit against Hikma AMRN Amarin $6.31 / +0.11 (+1.78%) 01/08/21 Piper Sandler Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target 12/28/20 Cantor Fitzgerald Vascepa showing positive year-over-year trends, says Cantor Fitzgerald 12/23/20 Goldman Sachs Amarin price target lowered to $6 from $8 at Goldman Sachs 12/14/20 Piper Sandler Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper AMRN Amarin $6.31 / +0.11 (+1.78%) 01/07/21 Amarin sees FY20 revenue up 42% to $610M, consensus $619.19M 11/05/20 Amarin reports Q3 non-GAAP EPS (1c), consensus 1c 08/04/20 Amarin reports Q2 adjusted EPS 4c, consensus (7c) AMRN Amarin $6.31 / +0.11 (+1.78%) 11/04/20 Amarin loses bid for rehearing of Vascepa case, Bloomberg says AMRN Amarin $6.31 / +0.11 (+1.78%) 12/14/20 Amarin rises following 'encouraging' results in COVID patients 10/26/20 Fly Intel: Pre-market Movers 10/15/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: Wall Street's top stories for Wednesday 03/01/21 41st Annual Healthcare Virtual Conference AMRN Amarin $6.31 / +0.11 (+1.78%) 01/08/21 Amarin call volume above normal and directionally bullish 01/04/21 Amarin call volume above normal and directionally bullish 12/17/20 Amarin call volume above normal and directionally bullish 12/14/20 Unusually active option classes on open December 14th
On The Fly	FuboTV jumps as Barrington says buy, Einhorn highlights gains » 13:48 01/21/21 01/21 13:48 01/21/21 13:48 FUBO FuboTV $34.78 / +4.66 (+15.47%) , REZI Resideo $25.01 / -0.63 (-2.46%) , DNMR Danimer Scientific $38.84 / +4.49 (+13.07%) , NCR NCR Corp. $33.85 / -0.16 (-0.47%) , CHNG Change Healthcare $24.05 / + (+0.00%) Shares of FuboTV (FUBO)… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options REZI NCR FUBO DNMR CHNG REZI Resideo $25.01 / -0.63 (-2.46%) 12/17/20 Resideo names Travis Merrill Executive VP, Chief Strategy & Commercial Office 11/16/20 Einhorn's Greenlight buys Twitter, exits Whirlpool in Q3 11/05/20 Resideo rises 35.1% NCR NCR Corp. $33.85 / -0.16 (-0.47%) 01/11/21 NCR Corp. confirms offer to acquire Cardtronics for $39.00 per share in cash 01/11/21 NCR Corp. confirms offer to acquire Cardtronics for $39.00 per share in cash FUBO FuboTV $34.78 / +4.66 (+15.47%) 01/21/21 Greenlight discloses new positions in Resideo and NCR, discusses FuboTV stake 01/21/21 Greenlight says FuboTV bear case misunderstands sports wagering opportunity 01/21/21 Greenlight owns shares, warrants of FuboTV at average price of $5 01/21/21 FuboTV rises 8.0% DNMR Danimer Scientific $38.84 / +4.49 (+13.07%) 01/21/21 Danimer Scientific rises 10.2% 01/21/21 Danimer Scientific rises 12.1% 01/20/21 Danimer Scientific rises 12.8% CHNG Change Healthcare $24.05 / + (+0.00%) 01/14/21 Microsoft, Oracle, Salseforce, others form Vaccination Credential Initiative 01/06/21 Change Healthcare jumps 37% to $25.10 after agreeing to merge with UnitedHealth 01/06/21 UnitedHealth's Optum to acquire Change Healthcare for $25.75 per share in cash 01/06/21 UnitedHealth's Optum to acquire Change Healthcare for $25.75 per share in cash FUBO REZI DNMR NCR CHNG FUBO FuboTV $34.78 / +4.66 (+15.47%) 01/21/21 Barrington FuboTV initiated with an Outperform at Barrington 01/19/21 LightShed Partners FuboTV price target lowered to $6.50 from $8 at LightShed Partners 01/12/21 Roth Capital FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital 01/12/21 Wedbush Wedbush 'not banking on' FuboTV's 'interesting' sports betting opportunity yet REZI Resideo $25.01 / -0.63 (-2.46%) 12/21/20 JPMorgan Resideo initiated with an Overweight at JPMorgan 12/14/20 Evercore ISI Resideo initiated with an Outperform at Evercore ISI 11/06/20 Roth Capital Resideo upgraded to Buy from Neutral at Roth Capital 08/12/20 Imperial Capital Resideo upgraded to Outperform from In-Line at Imperial Capital DNMR Danimer Scientific $38.84 / +4.49 (+13.07%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies NCR NCR Corp. $33.85 / -0.16 (-0.47%) 01/11/21 Wells Fargo Wells Fargo not ruling out counter-bid for Cardtronics slightly higher than $39 01/11/21 JPMorgan NCR bid for Cardtronics makes sense, says JPMorgan 01/11/21 Stephens NCR Corp. price target raised to $49 from $39 at Stephens 12/14/20 Craig-Hallum Par Technology price target raised to $75 from $55 at Craig-Hallum CHNG Change Healthcare $24.05 / + (+0.00%) 01/11/21 Berenberg Change Healthcare downgraded to Hold from Buy at Berenberg 01/07/21 Deutsche Bank Change Healthcare downgraded to Hold from Buy at Deutsche Bank 01/07/21 Cantor Fitzgerald Change Healthcare downgraded to Neutral from Overweight at Cantor Fitzgerald 01/07/21 Wells Fargo Change Healthcare downgraded to Equal Weight from Overweight at Wells Fargo REZI NCR FUBO CHNG REZI Resideo $25.01 / -0.63 (-2.46%) 11/05/20 Resideo sees Q4 revenue $1.36B-$1.41B, consensus $1.3B 11/05/20 Resideo reports Q3 EPS 60c, consensus 5c 08/04/20 Resideo reports Q2 adjusted EPS 17c, consensus 4c NCR NCR Corp. $33.85 / -0.16 (-0.47%) 10/27/20 NCR Corp. reports Q3 EPS 54c, consensus 39c 07/28/20 NCR Corp. says 2020 outlook remains withdrawn 07/28/20 NCR Corp. reports Q2 EPS 27c, consensus 21c FUBO FuboTV $34.78 / +4.66 (+15.47%) 01/05/21 FuboTV reports preliminary Q4 revenue $94M-$98M, consensus $87.36M 11/10/20 FuboTV sees FY21 revenue $415M-$435M, up 70% from last year, consensus $413.5M 11/10/20 FuboTV sees Q4 revenue $80M-$85M, consensus $77.22M. 11/10/20 FuboTV reports Q3 EPS ($1.65), consensus (37c) CHNG Change Healthcare $24.05 / + (+0.00%) 11/04/20 Change Healthcare sees Q3 EPS 28c-33c, consensus 29c 11/04/20 Change Healthcare reports Q2 EPS 32c, consensus 25c 11/04/20 Notable companies reporting after market close 09/09/20 Change Healthcare raises Q2 adj. EPS view to 24c-28c from 20c-23c, consensus 22c 30 Dec 18 Nov 08 Oct 07 Aug NCR NCR NCR Corp. $33.85 / -0.16 (-0.47%) 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 10/27/20 Synnex, NCR Corp. revealed as new holdings by Greenlight, Bloomberg says REZI NCR FUBO DNMR CHNG REZI Resideo $25.01 / -0.63 (-2.46%) 11/16/20 Fly Intel: Wall Street's top stories for Monday 11/16/20 Fly Intel: Wall Street's top stories at midday NCR NCR Corp. $33.85 / -0.16 (-0.47%) 01/11/21 Fly Intel: Pre-market Movers 07/28/20 Fly Intel: After-Hours Movers FUBO FuboTV $34.78 / +4.66 (+15.47%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday DNMR Danimer Scientific $38.84 / +4.49 (+13.07%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday CHNG Change Healthcare $24.05 / + (+0.00%) 01/06/21 Fly Intel: Pre-market Movers 09:00 Today Danimer Scientific - DNMR 02/04/21 Change Healthcare - CHNG FUBO DNMR CHNG FUBO FuboTV $34.78 / +4.66 (+15.47%) 01/12/21 Unusually active option classes on open January 12th 01/05/21 Largest borrow rate increases among liquid names 01/04/21 Largest borrow rate increases among liquid names 12/30/20 Unusually active option classes on open December 30th DNMR Danimer Scientific $38.84 / +4.49 (+13.07%) 01/07/21 Three new option listings and one option delisting on January 7th CHNG Change Healthcare $24.05 / + (+0.00%) 11/04/20 Unusual call flow in option market yesterday 11/03/20 Call buyer in Change Healthcare opens 17-day upside earnings/election play 07/31/20 Change Healthcare call volume above normal and directionally bullish

Wednesday
Hot Stocks	Align Technology establishes global corporate headquarters in Tempe » 08:32 01/20/21 01/20 08:32 01/20/21 08:32 ALGN Align Technology $557.46 / -10.12 (-1.78%) Align Technology… Align Technology announced that it established its new global corporate headquarters in Tempe, Arizona, effective January 1. The company's San Jose campus remains the hub for its global innovation, product, and marketing organization and will become home to its new Digital Innovation Center, currently under construction. As part of the new corporate headquarters move, Align Technology President and CEO Joe Hogan, CFO and Senior Vice President, Global Finance John Morici, Senior Vice President, Chief Legal and Regulatory Officer Julie Coletti, and Senior Vice President, Global HR Stuart Hockridge have relocated their offices to Tempe. Approximately 150 employees, mostly in corporate general and administrative roles, have been offered relocation packages. These employees have the option to relocate to Tempe or to continue working from their current locations. Relocation is not required and there are no layoffs associated with this move. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ALGN Align Technology $557.46 / -10.12 (-1.78%) 11/18/20 Align says ITC reverses ALJ finding that 3Shape indirectly Infringed patent 11/05/20 Align Technology's Olson sells 2,100 common shares 11/04/20 Align Technology's Morrow sells 5,000 common shares 10/21/20 Align Technology jumps 23% to $414 after Q3 earnings beat ALGN Align Technology $557.46 / -10.12 (-1.78%) 01/04/21 Evercore ISI Align Technology upgraded to Outperform from In Line at Evercore ISI 01/04/21 Evercore ISI Align Technology upgraded to Outperform from In Line at Evercore ISI 11/24/20 SVB Leerink Align Technology price target raised to $520 from $460 at SVB Leerink 11/24/20 Credit Suisse Align Technology price target raised to $515 from $432 at Credit Suisse ALGN Align Technology $557.46 / -10.12 (-1.78%) 10/21/20 Align Technology reports Q3 EPS $2.25, consensus 54c 10/21/20 Notable companies reporting after market close 07/22/20 Align Technology reports Q2 EPS (35c), consensus (4c) 07/22/20 Notable companies reporting after market close ALGN Align Technology $557.46 / -10.12 (-1.78%) 11/02/20 Fly Insider: Live Oak Bancshares, Zoom Video among week's notable insider trades 10/22/20 Fly Intel: Wall Street's top stories for Thursday 10/22/20 Fly Intel: Wall Street's top stories at midday 10/21/20 Fly Intel: After-Hours Movers 02/03/21 Align Technology - ALGN ALGN Align Technology $557.46 / -10.12 (-1.78%) 10/28/20 Align Technology put volume heavy and directionally bearish

Hot Stocks	Progenity reaches 2M test milestone » 07:31 01/20/21 01/20 07:31 01/20/21 07:31 PROG Progenity $6.34 / +0.89 (+16.33%) Progenity has reported… Progenity has reported the completion of two million diagnostic tests by its CLIA-certified and CAP-accredited laboratory in Ann Arbor, Michigan. This notable milestone comes as Progenity celebrates the ten-year anniversary of the company's founding. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PROG Progenity $6.34 / +0.89 (+16.33%) 01/05/21 Progenity Inc trading resumes 01/05/21 Progenity Inc trading halted, volatility trading pause 12/17/20 Progenity expands availability of COVID-19 PCR testing services 12/16/20 Progenity COO buys 63.9K shares of common stock PROG Progenity $6.34 / +0.89 (+16.33%) 01/14/21 Piper Sandler Progenity price target lowered to $10 from $15 at Piper Sandler 12/08/20 Piper Sandler Progenity shares not trading on fundamentals, says Piper Sandler 11/10/20 Piper Sandler Progenity price target lowered to $15 from $17 at Piper Sandler 10/29/20 Piper Sandler Piper Sandler still likes Progenity despite 'spooky' Q3 miss PROG Progenity $6.34 / +0.89 (+16.33%) 10/29/20 Progenity sees Q3 revenue $25M-$26M, consensus $34.74M 08/13/20 Progenity reports Q2 EPS ($6.11), consensus (83c) 03 Dec 19 Jun PROG Progenity $6.34 / +0.89 (+16.33%) 12/16/20 Fly Intel: After-Hours Movers 12/07/20 Fly Insider: Foot Locker, Alexion among weeks notable insider trades 08/13/20 Fly Intel: After-Hours Movers PROG Progenity $6.34 / +0.89 (+16.33%) 01/06/21 Fifteen new option listings on January 6th
Syndicate	Fulcrum Therapeutics 4M share Spot Secondary priced at $11.00 » 06:07 01/20/21 01/20 06:07 01/20/21 06:07 FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) SVB Leerink, Piper… SVB Leerink, Piper Sandler and Credit Suisse acted as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 12/14/20 X4 Pharmaceuticals appoints Diego Cadavid as CMO 12/09/20 Fulcrum Therapeutics to host KOL event on FTX-6058 for sickle cell disease 12/06/20 Fulcrum Therapeutics presents updated data on SCD program 11/10/20 Fulcrum Therapeutics: Curtis Oltmans to join as general counsel FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 10/15/20 Piper Sandler Fulcrum Therapeutics initiated with an Overweight at Piper Sandler 08/12/20 Fly Intel: Top five analyst downgrades 08/12/20 BTIG Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG 08/12/20 Morgan Stanley Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11 FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 11/10/20 Fulcrum Therapeutics reports Q3 EPS (70c), consensus (65c) 08/11/20 Fulcrum Therapeutics reports Q2 EPS (66c), consensus (78c) 20 Jan FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 08/11/20 Fly Intel: Wall Street's top stories for Tuesday 08/11/20 Fly Intel: Wall Street's top stories at midday
Downgrade	ShockWave Medical downgraded to Neutral from Overweight at Piper Sandler » 05:00 01/20/21 01/20 05:00 01/20/21 05:00 SWAV ShockWave Medical $142.06 / +5 (+3.65%) Piper Sandler analyst… Piper Sandler analyst Adam Maeder downgraded ShockWave Medical to Neutral from Overweight with a price target of $132, up from $96. The analyst steps to the sidelines "for the time being due to valuation." Additionally, he believes the resurgence of COVID-19 cases and "fairly high" buy-side expectations make for a "less-than-optimal" setup heading into the Q4 results. Maeder thinks the stock already reflects some upside to numbers and is unsure how much more multiple expansion will materialize over the next 12 months. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events SWAV ShockWave Medical $142.06 / +5 (+3.65%) 12/04/20 ShockWave Medical says CMS creates four new codes for IVL procedures 11/08/20 ShockWave announces unveiling of data from Disrupt PAD III study 10/15/20 ShockWave reports Disrupt CAD III met primary safety, effectiveness endpoints 10/01/20 ShockWave Medical announces updated time for CAD III Investor Webcast Event SWAV ShockWave Medical $142.06 / +5 (+3.65%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 01/12/21 Wells Fargo ShockWave Medical price target raised to $134 from $95 at Wells Fargo 12/03/20 Piper Sandler Piper boosts ShockWave Medical target to $96, likes setup into 2021 12/02/20 Oppenheimer Oppenheimer stays at Perform on ShockWave, highlights paper on IVL-induced VFib SWAV ShockWave Medical $142.06 / +5 (+3.65%) 11/09/20 ShockWave Medical reports Q3 EPS (38c), consensus (55c) 08/11/20 ShockWave Medical reports Q2 EPS (56c), consensus (62c) 17 Jun 02/17/21 ShockWave Medical - SWAV
Recommendations	Omnicell price target raised to $140 from $125 at Benchmark » 04:57 01/20/21 01/20 04:57 01/20/21 04:57 OMCL Omnicell $121.56 / +0.71 (+0.59%) Benchmark analyst Bill… Benchmark analyst Bill Sutherland raised the firm's price target on Omnicell to $140 from $125 and keeps a Buy rating on the shares after the company last week issued a preliminary Q4 beat, increased 2021 guidance and established 2025 growth targets that include five-year annual growth of 50% for its software-as-a-service and technology enabled service offerings. The strong outlook reflects the increased stress on hospital pharmacy management during the pandemic and a greater recognition of Omnicell's automated pharmacy benefits, Sutherland tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events OMCL Omnicell $121.56 / +0.71 (+0.59%) 12/08/20 Omnicell jumps 16.5% to $128 after reported takeover interest from Baxter 08/12/20 Omnicell to acquire 340B Link business from PSG for $225M 07/28/20 Omnicell remains unable to provide FY20 guidance at this time 07/28/20 Omnicell confident in overall health of business OMCL Omnicell $121.56 / +0.71 (+0.59%) 01/14/21 Craig-Hallum Omnicell price target raised to $142 from $100 at Craig-Hallum 12/09/20 Piper Sandler Pontential Baxter, Omnicell deal makes sense, says Piper Sandler 12/09/20 Benchmark Omnicell price target raised to $125 from $100 at Benchmark 12/08/20 Berenberg Berenberg starts four healthcare technology companies with Buy ratings OMCL Omnicell $121.56 / +0.71 (+0.59%) 01/13/21 Omnicell sees FY21EPS $3.38-$3.58, consensus $3.10 01/13/21 Omnicell raises FY20 EPS view to $2.46-$2.51, consensus $2.38 01/13/21 Omnicell raises FY20 EPS view to $2.46-$2.51, consensus $2.38 10/27/20 Omnicell sees FY21 revenue $1.015B-$1.045B, consensus $990.76M OMCL Omnicell $121.56 / +0.71 (+0.59%) 12/09/20 Baxter willing to pay over $125 per share for Omnicell, CNBC reports 12/09/20 Baxter not willing to go hostile to acquire Omnicell, CNBC reports 12/09/20 Omnicell board rejected Baxter takeover bid, CNBC reports 12/09/20 Baxter willing to pay over $125 per share for Omnicell, CNBC reports OMCL Omnicell $121.56 / +0.71 (+0.59%) 12/09/20 Fly Intel: Wall Street's top stories for Wednesday 12/09/20 Fly Intel: Wall Street's top stories at midday 12/09/20 Fly Intel: Pre-market Movers 12/08/20 Fly Intel: After-Hours Movers 02/01/21 Omnicell - OMCL

Tuesday
Hot Stocks	Inspire appoints Bryan Phillips as chief compliance officer, general counsel » 16:08 01/19/21 01/19 16:08 01/19/21 16:08 INSP Inspire Medical $224.07 / +14.13 (+6.73%) , CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) Inspire Medical (INSP)… Inspire Medical (INSP) announced the appointment of Bryan Phillips as senior VP, general counsel, chief compliance officer and corporate secretary. Phillips is a legal executive with broad corporate experience in the healthcare industry.Most recently, Phillips served as chief legal officer at Cerevel Therapeutics (CERE). ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP CERE INSP Inspire Medical $224.07 / +14.13 (+6.73%) 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% 10/22/20 Inspire Medical appoints Shelley Broader to board of directors 09/01/20 Inspire Medical announces Humana coverage for Inspire Therapy CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) 01/19/21 Frequency Therapeutics appoints Quentin McCubbin as chief manufacturing officer 12/08/20 Cerevel Therapeutics appoints Ruth McKernan to board of directors 10/30/20 Cerevel Therapeutics doses first patients in Phase 3 trials of tavapadon 10/28/20 Cerevel Therapeutics debuts as publicly-traded neuroscience company INSP CERE INSP Inspire Medical $224.07 / +14.13 (+6.73%) 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street 01/04/21 BofA Inspire Medical downgraded to Neutral from Buy at BofA 12/15/20 Goldman Sachs Inspire Medical downgraded to Neutral from Buy at Goldman Sachs 12/03/20 Piper Sandler Inspire Medical price target raised to $210 from $147 at Piper Sandler CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) 12/10/20 Goldman Sachs Cerevel Therapeutics initiated with a Buy at Goldman Sachs 11/23/20 Jefferies Cerevel Therapeutics initiated with a Buy at Jefferies 11/09/20 Fly Intel: Top five analyst initiations 11/09/20 Stifel Cerevel Therapeutics initiated with a Buy at Stifel INSP INSP Inspire Medical $224.07 / +14.13 (+6.73%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 08/04/20 Inspire Medical reports Q2 EPS (88c), consensus ($1.10) 14 Apr INSP CERE INSP Inspire Medical $224.07 / +14.13 (+6.73%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades

On The Fly

News and insights, exclusive to thefly.com

15:39	On The Fly: Weekly technical notes for Russell 2000»
15:39	On The Fly: Weekly technical notes for S&P 500»
09:55	Fly Intel: Top five analyst initiations»
09:55	Fly Intel: Top five analyst downgrades»
09:55	Fly Intel: Top five analyst upgrades»

View all On The Fly Stories »

Upcoming
Events (10)

AUPH	PDUFA Date for Voclosporin
AOUT	Virtual Outdoor Day
MNGPF	Quant & Derivatives Virtual Conference
	2021 VESS Annual Winter Meeting
	Western Institutional Investor Virtual Conference
	Aesthetics Tech Virtual Summit 2021
	Early Cancer Screening, Diagnostics Reimbursement and Genomic Tools KOL Day
OTRK	Ontrak
NMTR	9 Meters Biopharma
TA	TravelCenters

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals for your search.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial